Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

60 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Viral Shedding 1 Year Following First-Episode Genital HSV-1 Infection.
Johnston C, Magaret A, Son H, Stern M, Rathbun M, Renner D, Szpara M, Gunby S, Ott M, Jing L, Campbell VL, Huang ML, Selke S, Jerome KR, Koelle DM, Wald A. Johnston C, et al. Among authors: campbell vl. JAMA. 2022 Nov 1;328(17):1730-1739. doi: 10.1001/jama.2022.19061. JAMA. 2022. PMID: 36272098 Free PMC article.
Genome-Wide Approach to the CD4 T-Cell Response to Human Herpesvirus 6B.
Hanson DJ, Tsvetkova O, Rerolle GF, Greninger AL, Sette A, Jing L, Campbell VL, Koelle DM. Hanson DJ, et al. Among authors: campbell vl. J Virol. 2019 Jun 28;93(14):e00321-19. doi: 10.1128/JVI.00321-19. Print 2019 Jul 15. J Virol. 2019. PMID: 31043533 Free PMC article.
Human CD4+ T Cells Specific for Merkel Cell Polyomavirus Localize to Merkel Cell Carcinomas and Target a Required Oncogenic Domain.
Longino NV, Yang J, Iyer JG, Ibrani D, Chow IT, Laing KJ, Campbell VL, Paulson KG, Kulikauskas RM, Church CD, James EA, Nghiem P, Kwok WW, Koelle DM. Longino NV, et al. Among authors: campbell vl. Cancer Immunol Res. 2019 Oct;7(10):1727-1739. doi: 10.1158/2326-6066.CIR-19-0103. Epub 2019 Aug 12. Cancer Immunol Res. 2019. PMID: 31405946 Free PMC article.
Proteome-Wide Zika Virus CD4 T Cell Epitope and HLA Restriction Determination.
Campbell VL, Nguyen L, Snoey E, McClurkan CL, Laing KJ, Dong L, Sette A, Lindestam Arlehamn CS, Altmann DM, Boyton RJ, Roby JA, Gale M Jr, Stone M, Busch MP, Norris PJ, Koelle DM. Campbell VL, et al. Immunohorizons. 2020 Aug 4;4(8):444-453. doi: 10.4049/immunohorizons.2000068. Immunohorizons. 2020. PMID: 32753403 Free PMC article.
Clinical, laboratory, and temporal predictors of neutralizing antibodies to SARS-CoV-2 after COVID-19.
Boonyaratanakornkit J, Morishima C, Selke S, Zamora D, McGuffin S, Shapiro AE, Campbell VL, McClurkan CL, Jing L, Gross R, Liang J, Postnikova E, Mazur S, Chaudhary A, Das MK, Fink SL, Bryan A, Greninger AL, Jerome KR, Holbrook MR, Gernsheimer TB, Wener MH, Wald A, Koelle DM. Boonyaratanakornkit J, et al. Among authors: campbell vl. medRxiv [Preprint]. 2020 Oct 21:2020.10.06.20207472. doi: 10.1101/2020.10.06.20207472. medRxiv. 2020. PMID: 33052361 Free PMC article. Updated. Preprint.
Clinical, laboratory, and temporal predictors of neutralizing antibodies against SARS-CoV-2 among COVID-19 convalescent plasma donor candidates.
Boonyaratanakornkit J, Morishima C, Selke S, Zamora D, McGuffin S, Shapiro AE, Campbell VL, McClurkan CL, Jing L, Gross R, Liang J, Postnikova E, Mazur S, Lukin VV, Chaudhary A, Das MK, Fink SL, Bryan A, Greninger AL, Jerome KR, Holbrook MR, Gernsheimer TB, Wener MH, Wald A, Koelle DM. Boonyaratanakornkit J, et al. Among authors: campbell vl. J Clin Invest. 2021 Feb 1;131(3):e144930. doi: 10.1172/JCI144930. J Clin Invest. 2021. PMID: 33320842 Free PMC article. Clinical Trial.
Homologous and Heterologous Covid-19 Booster Vaccinations.
Atmar RL, Lyke KE, Deming ME, Jackson LA, Branche AR, El Sahly HM, Rostad CA, Martin JM, Johnston C, Rupp RE, Mulligan MJ, Brady RC, Frenck RW Jr, Bäcker M, Kottkamp AC, Babu TM, Rajakumar K, Edupuganti S, Dobrzynski D, Coler RN, Posavad CM, Archer JI, Crandon S, Nayak SU, Szydlo D, Zemanek JA, Dominguez Islas CP, Brown ER, Suthar MS, McElrath MJ, McDermott AB, O'Connell SE, Montefiori DC, Eaton A, Neuzil KM, Stephens DS, Roberts PC, Beigel JH; DMID 21-0012 Study Group. Atmar RL, et al. N Engl J Med. 2022 Mar 17;386(11):1046-1057. doi: 10.1056/NEJMoa2116414. Epub 2022 Jan 26. N Engl J Med. 2022. PMID: 35081293 Free PMC article. Clinical Trial.
T cell response to intact SARS-CoV-2 includes coronavirus cross-reactive and variant-specific components.
Jing L, Wu X, Krist MP, Hsiang TY, Campbell VL, McClurkan CL, Favors SM, Hemingway LA, Godornes C, Tong DQ, Selke S, LeClair AC, Pyo CW, Geraghty DE, Laing KJ, Wald A, Gale M, Koelle DM. Jing L, et al. Among authors: campbell vl. medRxiv [Preprint]. 2022 Jan 25:2022.01.23.22269497. doi: 10.1101/2022.01.23.22269497. medRxiv. 2022. PMID: 35118477 Free PMC article. Updated. Preprint.
T cell response to intact SARS-CoV-2 includes coronavirus cross-reactive and variant-specific components.
Jing L, Wu X, Krist MP, Hsiang TY, Campbell VL, McClurkan CL, Favors SM, Hemingway LA, Godornes C, Tong DQ, Selke S, LeClair AC, Pyo CW, Geraghty DE, Laing KJ, Wald A, Gale M Jr, Koelle DM. Jing L, et al. Among authors: campbell vl. JCI Insight. 2022 Mar 22;7(6):e158126. doi: 10.1172/jci.insight.158126. JCI Insight. 2022. PMID: 35133988 Free PMC article.
60 results